Introduction {#s1}
============

Organelles are essential for cellular functions, and organelle inheritance is likely a major pathway that ensures the presence of organelles in all cells. A requirement for the inheritance of the mammalian Golgi is well established due in part to the elaborate changes in architecture that occur during interphase vs mitosis ([@bib54]). For other organelles, which are constitutively dispersed, organized mechanisms for their inheritance remain less clear. The budding yeast *Saccharomyces cerevisiae* provides an excellent model to study the spatial and temporal control of organelle inheritance, in part because its cell division is asymmetric. This asymmetric division requires active organelle transport in each cell-cycle. In budding yeast, most of the organelles are transmitted from mother to daughter cells ([@bib25]). These include the vacuole/lysosome, mitochondria, the endoplasmic reticulum, peroxisomes, secretory vesicles and late-Golgi elements. Transport of these organelles starts in G1 phase and occurs in coordination with the cell-cycle. However, it is unclear whether there are mechanisms that guarantee the presence of organelles prior to the next round of cell division. Here we present the unexpected finding that the presence of the vacuole is ensured because the vacuole plays an essential role in the initiation of the cell-cycle.

During cell division in budding yeast, the daughter cell inherits a vacuole from the mother cell ([@bib64]). The vacuole is transported by a vacuole transport complex, composed of the myosin V motor Myo2, the vacuole membrane anchored protein Vac8, and an adaptor protein Vac17 that links Myo2 and Vac8 ([@bib14]; [@bib62]; [@bib30]; [@bib58]). Vacuole inheritance is initiated in G1 phase via Cdk1/Cdc28, which regulates the formation of the vacuole transport complex ([@bib48]). After formation of the complex, Myo2 moves the vacuole to the daughter cell along actin cables ([@bib29]). At the end of the cell-cycle, vacuole transport is terminated by ubiquitylation of Vac17, which is then degraded by the 26S proteasome ([@bib66]). Notably, Myo2 also delivers other cargoes including mitochondria, peroxisomes, secretory vesicles, late-Golgi elements, and astral microtubules. Myo2 binds to each cargo via cargo specific adaptors, which attach to the globular tail domain of Myo2 ([@bib67]; [@bib32]; [@bib9]; [@bib31]; [@bib23]; [@bib3]; [@bib40]; [@bib36]; [@bib53]; [@bib22]; [@bib16]). Moreover, some of the regulatory pathways for vacuole transport are also utilized by other Myo2 cargoes ([@bib45]; [@bib48]; [@bib24]; [@bib37]; [@bib66]).

Many of the proteins involved in vacuole inheritance are conserved among several species, which suggests that vacuole inheritance confers a selective advantage ([@bib44]). These observations suggest that the vacuole plays essential roles. Surprisingly, mutations that block vacuole inheritance do not have a notable impact on cell viability ([@bib14]; [@bib30]). Indeed, previous studies suggest that new vacuole synthesis occurs in the absence of vacuole inheritance ([@bib65]; [@bib27]), however at the time of those studies, there were no suitable methods to distinguish an old vacuole from newly formed vacuoles. Moreover the origin of the new vacuole was unknown. Importantly it was not clear how many pathways would need to be blocked in order to prevent vacuole biogenesis. Note that vacuole biogenesis utilizes at least three direct transport pathways: autophagy/Cvt (from the cytoplasm), AP-3/ALP (from the Golgi), and CPY (from the MVB/endosome) pathways ([@bib11]; [@bib28]).

Results and discussion {#s2}
======================

To test when and where a new vacuole is generated in the absence of vacuole inheritance, we monitored for the presence of a vacuole using two markers, Vph1 and FM4-64. Vacuoles were detected using GFP fused to the integral vacuole membrane protein Vph1, a V~0~ subunit of the vacuolar ATPase ([@bib43]). The presence of inherited vacuoles or old vacuoles were specifically assessed via pulse chase experiments with the vital fluorophore FM4-64 ([@bib61]). Exogenously added FM4-64 binds to the plasma membrane, is internalized by endocytosis and delivered to the vacuole. After a chase of one doubling time, all of the FM4-64 is trapped on the vacuole membrane. In wild-type cells, the vacuole is inherited and FM4-64 is distributed between the mother and daughter vacuole ([@bib63]), and Vph1-GFP and FM4-64 always colocalize ([Figure 1A](#fig1){ref-type="fig"}, top panels). In contrast, in the vacuole inheritance mutant *vac17Δ*, FM4-64 is retained in the mother cell ([@bib30]). Interestingly in *vac17Δ*, buds contained small Vph1-GFP positive vacuoles that lack FM4-64 ([Figure 1A](#fig1){ref-type="fig"}; open white allow heads, see also \[[@bib2]\]). This observation indicates that there is new vacuole synthesis in the absence of vacuole inheritance, and that the new synthesis initiates in the bud.10.7554/eLife.08160.003Figure 1.Yeast require vacuoles of a specific size prior to formation of a bud.(**A**) Wild-type and *vac17Δ*cells which express Vph1-GFP from its endogenous locus, were pulse labeled with the vacuole specific dye FM4-64. Wild-type cells have both FM4-64 and Vph1-GFP signals in both mother and daughter cells. *vac17Δ* cells have both Vph1-GFP and FM4-64 on the vacuole in old mother cells, however the daughter cells solely have a Vph1-GFP labeled vacuole. White arrowheads; new vacuoles in daughter cells. Yellow arrowheads; new vacuoles in new mother cells. Dashed line; outline of cells. (**B**) (Left panel) A new cell does not form a bud until its vacuole reaches a specific size. Graph indicates the vacuole diameter of wild-type, *vac17Δ* old cell and *vac17Δ* new cells with no bud and mother cells with a small bud (less than 20% of diameter of the mother cell). Cell/vacuole diameter was measured by ImageJ. Each cell/vacuole diameter was normalized to its mother cell diameter. Black arrow; minimum size of mother vacuoles in cells with a bud. Average in each category (red bar). Error bar; standard deviation (SD). Not a significant difference; ns, p-value \> 0.10. A statistically significant difference; \*\*\* (p-value \< 1 × 10^−3^). (Right panel) The vacuoles of the new mother cells of *vac17Δ* grow faster than vacuoles in either a wild-type or *vac17Δ* old mother cell. Scatter plots of bud sizes and mother vacuole sizes.**DOI:** [http://dx.doi.org/10.7554/eLife.08160.003](10.7554/eLife.08160.003)10.7554/eLife.08160.004Figure 1---figure supplement 1.Yeast require vacuoles of a specific size prior to formation of a bud.(**A**) Schematic of diameters measured. (**B**) Vacuole diameter is proportional with the cell diameter. Scatter plot of cell diameter and vacuole diameter in mother and daughter cells. (**C**) When viewed across the cell-cycle, the increase in vacuole size of *vac17Δ* new cells is greater than either wild-type or *vac17Δ* old cells. Trend lines from linear equations of data from wild-type (black line); *vac17Δ* old mother cells (pink line), and *vac17Δ* new mother cells (green line) are shown. (**D**) Vacuole inheritance is important for regulating vacuole size in the mother cell. The vacuole size of *vac17Δ* old mother cells is larger than that of wild-type. Average in each category (red bar). Error bar; SD. \*\*\* (p-value \< 1 × 10^−4^). Middle line in box plot indicates the median of the data set. The upper edge of the box indicates the 75th percentile of the data set, and the lower edge indicates the 25th percentile.**DOI:** [http://dx.doi.org/10.7554/eLife.08160.004](10.7554/eLife.08160.004)

Yeast generates vacuoles of a specific size prior to formation of a bud {#s2-1}
-----------------------------------------------------------------------

The new mother cells of *vac17Δ*, which lack FM4-64 ([Figure 1A](#fig1){ref-type="fig"}; open yellow arrowheads), had larger vacuoles compared to the newly formed vacuoles in the large buds. These findings suggest that the newly generated vacuoles continue to grow. To establish the relationship between the size of the newly formed vacuoles with the size of unbudded cells or mother cells, we measured vacuole size vs cell size in wild-type and *vac17Δ* cells. In wild-type cells, the vacuole diameter showed a linear relationship with cell diameter ([Figure 1---figure supplement 1A,B](#fig1s1){ref-type="fig"}). This is consistent with a previous study that demonstrated that vacuole volume correlates with cell volume ([@bib15]). Notably, we found that in the *vac17Δ* mutant, the vacuoles grew prior to the generation of a bud ([Figure 1B](#fig1){ref-type="fig"}, black arrow). In unbudded new daughters of the *vac17Δ* mutant, the vacuole diameter relative to cell diameter was smaller than that of wild-type and *vac17Δ* unbudded old mother cells ([Figure 1B](#fig1){ref-type="fig"}, left panel). Notably, the average diameter of the vacuole was only 5.7(±1.5)% of the cell diameter in new unbudded *vac17Δ* cells. However, after production of a small bud, the average mother cell vacuole diameter was 10(±3.8)% of the cell diameter. In contrast, there was no significant increase in the relative percent diameter of the vacuoles in wild-type and *vac17Δ* old mother cells with or without a small bud. These observations show that the vacuoles in the new daughter cells grow to a minimum size prior to producing a bud. This growth occurs either because a minimum vacuole size is required and/or because the vacuole needs to mature prior to the generation of a bud.

Note that the vacuoles in *vac17Δ* new mothers continued to grow, and grew faster than vacuoles in either wild-type or *vac17Δ* old mother cells ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}, green line vs the black/pink lines). These observations suggest that cells actively synthesize new vacuoles in the absence of inherited vacuoles, and further suggest that there are mechanisms that regulate vacuole size in proportion to cell size.

In addition, the average vacuole diameter relative to cell diameter of all the *vac17Δ* old mother cells was larger than that of wild-type and *vac17Δ* new mother cells ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). This suggests that vacuole inheritance is also important for regulating vacuole size in the mother cell.

The vacuole is required for cell growth {#s2-2}
---------------------------------------

We observed that all *vac17Δ* mother cells and unbudded cells have a vacuole as defined by the presence of Vph1-GFP. This strongly suggests that the vacuole is required for cell growth and viability. If this were true, then a combination of a vacuole inheritance defect with an additional defect in the synthesis of a new vacuole would render the cell inviable. Similarly, an additional defect in vacuole function(s) that are required for bud emergence would result in non-viable cells ([Figure 2A](#fig2){ref-type="fig"}). Indeed, a high-throughput screen suggested that over twenty genes might be synthetically lethal with the *vac17Δ* mutant ([@bib18]). We individually tested double mutants of *vac17Δ* with each of the previously proposed candidates that are not essential genes, and found that the double mutants, *vac17Δ pep12Δ* and *vac17Δ vps45Δ* displayed synthetic growth defects ([Figure 2B,C](#fig2){ref-type="fig"}). Importantly *pep12Δ* and *vps45Δ* were also synthetically lethal with additional mutants defective in vacuole inheritance, *vac8Δ* and *myo2-N1304D* mutants ([Figure 2---figure supplement 1A--D](#fig2s1){ref-type="fig"}). The corresponding wild-type genes, *PEP12* and *VPS45*, likely play a critical role in the generation of a new vacuole.10.7554/eLife.08160.005Figure 2.Pep12 and Vps45 are required for the synthesis of a new vacuole.(**A**) Schematic of pathways predicted to exhibit synthetic lethality with mutations in vacuole inheritance. When vacuole inheritance is defective, the bud generates a new vacuole that is independent of the mother vacuole. If vacuoles play an essential role, then cells with no mechanism to generate a vacuole will not be viable. Furthermore if the new vacuole is defective in its essential function(s), the cell will not be viable. (**B**) The *pep12Δ* and *vps45Δ* mutants exhibit a synthetic growth defect with *vac17Δ*. Results of tetrad dissection. Haploid colonies from tetrads derived from heterozygous diploids of *VAC17*/*vac17Δ PEP12*/*pep12Δ* and *VAC17*/*vac17Δ VPS45*/*vps45Δ* were arrayed vertically on YPD (rich medium) plates incubated at 24°C for 3 days. *vac17Δ* = *17Δ*; *pep12Δ* = *12Δ*; *vps45Δ* = *45Δ*; *vac17Δ pep12Δ* or *vac17Δ vps45Δ* double mutant = *ΔΔ* are indicated. (**C**) Quantification of colony size, relative to the average of wild-type colonies. A total of 28 full tetrads and 48 full tetrads were analyzed for *vac17Δ pep12Δ* and *vac17Δ vps45Δ*, respectively. Average size in each genotype (red bar). Error bar; SD. (**D**) Both vacuole inheritance and new synthesis are important to maintain functional vacuoles. In the *vac17Δ pep12Δ* mutant several cells appear to lack a vacuole. Wild-type cells incubated with 10 μM CMAC for 30 min exhibited a blue fluorescent signal in the vacuole lumen. The limiting membrane of the vacuole is indicated by Vph1-GFP expressed from its endogenous locus. Wild-type and *vac17Δ* cells show normal localization of Vph1-GFP and CMAC. Single *pep12Δ* cells show abnormal distribution in Vph1-GFP, but not CMAC. The *vac17Δ pep12Δ* double mutant cells show defects in the localization of Vph1-GFP and CMAC. (**E**) Quantification of cells with a CMAC positive subcellular structure. Any CMAC containing structure with or without Vph1-GFP was scored as a structure. Error bars; SD calculated from four independent experiments with at least 100 cells counted in each strain/experiment. (**F**) New vacuoles are generated from Pep12-positive endosomes. GFP-Pep12/Vph1-CFP expressed in wild-type and *vac17Δ*cells were pulse labeled with FM4-64. GFP-Pep12 and Vph1-CFP were expressed from the endogenous loci in both strains. Open arrowheads; new vacuoles. (**G**) Quantification of percent daughter cells with Vph1-CFP and/or GFP-Pep12 in *vac17Δ* cells. Averages from two independent experiments; at least 100 cells counted per experiment. Open circles and triangles indicate each experiment.**DOI:** [http://dx.doi.org/10.7554/eLife.08160.005](10.7554/eLife.08160.005)10.7554/eLife.08160.006Figure 2---figure supplement 1.Pep12 and Vps45 are required for the viability of vacuole inheritance mutants.(**A**) A *vac8Δ* mutant exhibits a synthetic growth defect with either *pep12Δ* and *vps45Δ*. Results of tetrad dissections of heterozygous diploids, *VAC8*/*vac8Δ PEP12*/*pep12Δ* and *VAC8*/*vac8Δ VPS45*/*vps45Δ*. *vac8Δ* = *8Δ*; *pep12Δ* = *12Δ*; *vps45Δ* = *45Δ*; *vac8Δ pep12Δ* or *vac8Δ vps45Δ* double mutant = *ΔΔ* are indicated. (**B**) Quantification of colony size, relative to average of wild-type colonies. A total 35 tetrads and 37 tetrads were analyzed for *vac8Δ pep12Δ* and *vac8Δ vps45Δ*, respectively. (**C**) The *pep12Δ* mutant exhibits a synthetic growth defect with *myo2-N1304D*, which is a vacuole inheritance mutant due to a defect in binding to Vac17. Survival occurs when wild-type *MYO2* is expressed in *myo2Δ* cells, and in the *myo2Δ pep12Δ* mutant. In addition, the *myo2-N1304D* mutant expressed in *myo2Δ* cells is sufficient for survival. In contrast, the *myo2-N1304D* mutant expressed in *myo2Δ pep12Δ* cells is lethal. Plasmids were transformed into a *myo2Δ* strain and a *myo2Δ pep12Δ* strain containing YCp50 \[*URA3*\] *MYO2*. Plasmids tested were pRS413 \[*HIS3*\] (mock), pRS413 *MYO2* (p*MYO2*), or pRS413 *myo2-N1304D* (p*myo2-N1304D*). Transformed colonies were cultured in SC-His-Ura liquid media and serial dilutions spotted onto SC+5-FOA plates to counter select against YCp50 \[*URA3*\] *MYO2* (middle panel) and the same culture was also tested on SC-His-Ura plate (right panel). (**D**) A *vps45Δ* mutant exhibits a synthetic growth defect with the *myo2-N1304D* mutant. Wild-type *MYO2* expressed in *myo2Δ* cells, or in the *myo2Δ vps45Δ* mutant, is sufficient for cell viability. In addition, the *myo2-N1304D* mutant expressed in *myo2Δ* cells is sufficient for cell viability. In contrast, the *myo2-N1304D* mutant expressed in *myo2Δ vps45Δ* cells is lethal.**DOI:** [http://dx.doi.org/10.7554/eLife.08160.006](10.7554/eLife.08160.006)

*PEP12* encodes a t-SNARE, and *VPS45* encodes a Sec1/Munc18 protein. These proteins function together in the vacuole-protein-sorting pathway from endosomes to the vacuole ([@bib7]; [@bib12]). To test whether the growth defects of the *vac17Δ pep12Δ* double mutant are due to a defect in forming new vacuoles, we monitored vacuoles using two markers, Vph1-GFP and CMAC, a small molecule that is taken into the lumen of the vacuole ([@bib56]). Wild-type and *vac17Δ* cells showed normal localization of Vph1-GFP and CMAC ([Figure 2D,E](#fig2){ref-type="fig"}). However, single *pep12Δ* cells, which have a defect in protein sorting to the vacuole, and a partial defect in vacuole inheritance ([@bib50]), showed an abnormal distribution of Vph1 ([@bib49]), but not CMAC ([Figure 2D,E](#fig2){ref-type="fig"}). The *vac17Δ pep12Δ* double mutant cells showed defects in the localization of Vph1 and CMAC ([Figure 2D,E](#fig2){ref-type="fig"}). These findings suggest that the double mutant does not generate normal vacuoles.

*PEP12* localization is consistent with its role in the synthesis of a new vacuole. GFP-Pep12 and Vph1-CFP were co-expressed in a *vac17Δ* mutant labeled with FM4-64. In this strain, 63% of *vac17Δ* cells had GFP-Pep12 on the newly synthesized vacuole in the bud, which was Vph1-CFP positive but lacked FM4-64 ([Figure 2F,G](#fig2){ref-type="fig"}). In 17% of daughter cells, GFP-Pep12 was present in buds without a vacuole, as indicated by the absence of Vph1-CFP (vacuole). This suggests that a Pep12-positive endosome appears first, and subsequently a Vph1-positive vacuole matures from the Pep12-positive endosome. Note that in only 1.6% of cells, Vph1-CFP was present without GFP-Pep12.

The vacuole is required for cell-cycle progression from early G1 {#s2-3}
----------------------------------------------------------------

That the vacuole in the mother cell must reach a specific size prior to bud emergence ([Figure 1B](#fig1){ref-type="fig"}) and that a vacuole is required for cell growth ([Figure 2](#fig2){ref-type="fig"}), raised the possibility that the vacuole is required for cell-cycle progression. Thus, we tested whether the *vac17 pep12* double mutant arrests at a specific point in the cell-cycle. To perform this analysis, we used the *pep12-60*^*tsf*^ mutant, which is *[t]{.ul}*emperature *[s]{.ul}*ensitive for *[f]{.ul}*unction (*tsf*). At elevated temperatures *PEP12* function is acutely ablated, but the cells remain viable ([@bib12]). Importantly, the *vac17Δ pep12-60*^*tsf*^ double mutant, but not *pep12-60*^*tsf*^ single mutant, showed a severe growth defect at 37°C ([Figure 3A](#fig3){ref-type="fig"}).10.7554/eLife.08160.007Figure 3.The vacuole is required for cell-cycle progression from early G1.(**A**) The *vac17Δ pep12-60*^*tsf*^ double mutant shows synthetic growth defects at the restrictive temperature, 37°C. Wild-type, *vac17Δ, pep12-60*^*tsf*^ and *vac17Δ pep12-60*^*tsf*^ strains were cultured in liquid media and serial dilutions were spotted onto YPD plates. The plates were incubated at 24°C, 30°C and 37°C for 2 days. (**B**) The *vac17Δ pep12-60*^*tsf*^ double mutant arrests in G1 phase at the restrictive temperature 37°C. Percent cells in G1 phase (solid lines). Yeast strains tested; wild-type, *vac17Δ*, *pep12-60*^*tsf*^, and *vac17Δ pep12-60*^*tsf*^. Cultures were incubated at 24°C overnight, and then sifted to 37°C for 0, 2, 4, 8, 12, or 24 hr. The percentage of G1 cells (1N DNA) was measured using propidium iodide (PI) staining and assessed by flow cytometry. The same cultures were analyzed for lethality (percent dead cells) (dashed lines). After incubation at 37°C, the number of yeast cells were assessed with a hemocytometer, and their ability to form colonies at 24°C on YPD plates was tested. Lethality was inferred from the number of cells that survived the treatment. Error bars; SD calculated from four independent experiments. \*\*\* (p-value \< 1 × 10^−3^). (**C**) The *vac17Δ pep12-60*^*tsf*^ double mutant arrests in early G1 phase at the restrictive temperature 37°C. Cells were scored for the presence of Whi5-3xGFP in the nucleus. Wild-type, *vac17Δ*, *pep12-60*^*tsf*^, and *vac17Δ pep12-60*^*tsf*^ cells, which express Whi5-3xGFP from its endogenous locus, were incubated at 24°C overnight, and then sifted to 37°C for 0 or 4 hr. Error bars; SD calculated from three independent experiments with at least 100 cells counted in each strain/experiment. \*\*\* (p-value \< 1 × 10^−3^). (**D**) Arrested cells that have 1N DNA content are unbudded. Wild-type and *vac17Δ pep12-60*^*tsf*^ cells were incubated at 24°C overnight, and then sifted to 37°C for 24 hr. After fixation, yeast were stained with PI, and cells with 1N DNA were sorted by flow cytometry. The sorted cells were observed by microscopy. For both wild-type and the *vac17Δ pep12-60*^*tsf*^ double mutant 99% of the cells with 1N DNA were unbudded. Sorted cells from three individual experiments were counted. At least 400 cells were counted for each experiment.**DOI:** [http://dx.doi.org/10.7554/eLife.08160.007](10.7554/eLife.08160.007)10.7554/eLife.08160.008Figure 3---figure supplement 1.The vacuole is required for cell-cycle progression from early G1 phase.(**A**) The *vac17Δ pep12-60*^*tsf*^ double mutant is arrested in G1 phase at the restrictive temperature, 37°C. Percent cells in G1 (1N DNA) and G2 (2N DNA) phase after incubation at 37°C for 0, 2, 4, 8, 12, or 24 hr. Percent cells arrested in G1 are also shown in [Figure 3B](#fig3){ref-type="fig"}. Error bars; SD calculated from four independent experiments. (**B**) *vac17Δ pep12Δ* and *vac17Δ vps45Δ* double mutants exhibit an accumulation of cells arrested in G1 phase. Flow cytometry analysis of PI staining of yeast strains; wild-type, *vac17Δ*, *pep12Δ*, *vps45Δ*, *vac17Δ pep12Δ*, and *vac17Δ vps45Δ*. (**C**) Quantification of percent cells in G1 and G2 phase. Error bars; SD calculated from four independent experiments. (**D**) The *vac17Δ pep12-60*^*tsf*^ double mutant arrests in early G1 phase at the restrictive temperature, 37°C. Wild-type, *vac17Δ*, *pep12-60*^*tsf*^, and *vac17Δ pep12-60*^*tsf*^ cells which express Whi5-3xGFP from its endogenous locus, were incubated at 24°C overnight, and then sifted to 37°C for 0 or 4 hr. Images of Whi5-3xGFP localization after cells were incubated at 37°C for 4 hr. Quantification is shown in [Figure 3C](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.08160.008](10.7554/eLife.08160.008)

To test cell-cycle progression, we labeled DNA with propidium iodide (PI), and measured DNA content via FACS analysis. Wild-type, *vac17Δ*, *pep12-60*^*tsf*^, and *vac17Δ pep12-60*^*tsf*^ cells were incubated overnight at 24°C, then shifted to 37°C. At 24°C (0 hr of 37°C), the *vac17Δ pep12-60*^*tsf*^ double mutant had a normal cell-cycle profile ([Figure 3B](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). After incubation at 37°C for 24 hr, wild-type, *vac17Δ* and *pep12-60*^*tsf*^ showed a similar percent of G1 phase cells (1N DNA); 46(±2)%, 48(±2)%, and 43(±3)%, respectively ([Figure 3B](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). In contrast, after incubation at the restrictive temperature for 24 hr, 80(±3)% of the *vac17Δ pep12-60*^*tsf*^ double mutant cells arrested at G1 phase (1N DNA). Importantly, at 8, 12 and 24 hr after the shift to 37°C, the differences between the *vac17Δ pep12-60*^*tsf*^ double mutant and the other strains were statistically significant (all p-values \< 1 × 10^−3^). Consistent with these findings, both the *vac17Δ pep12Δ* and *vac17Δ vps45Δ* double mutants exhibited an arrest in G1 phase ([Figure 3---figure supplements 1B,C](#fig3s1){ref-type="fig"}). These results strongly suggest that a functional vacuole is important for cell-cycle progression from G1 phase.

The finding that the *vac17Δ pep12-60*^*tsf*^ double mutant arrests in G1 phase, suggested that this might be the primary reason for the growth arrest ([Figure 3A](#fig3){ref-type="fig"}). To further test this hypothesis, we monitored cell viability at several time points following a shift to 37°C. Cells were counted with a hemocytometer, and the ability of these cells to form colonies at 24°C was assessed ([Figure 3B](#fig3){ref-type="fig"}). There was a measurable increase in the lethality of the *vac17Δ pep12-60*^*tsf*^ mutant. However the difference between the lethality of the *pep12-60*^*tsf*^ single mutant and the *vac17Δ pep12-60*^*tsf*^ double mutant was not statistically significant (p = 0.082) ([Figure 3B](#fig3){ref-type="fig"}). Together, these observations strongly suggest that cells without a functional vacuole arrest at G1 phase, and that this arrest is not an artifact of general cell death.

Additional evidence for a specific arrest in G1 phase, came from the finding that when the *vac17Δ pep12-60*^*tsf*^ mutant was incubated at the restrictive temperature, there was a striking increase of cells with Whi5 in the nucleus ([Figure 3C](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}). Whi5 is a transcriptional repressor of the SBF complex (Swi4-Swi6), and is localized in the nucleus in early G1 phase ([@bib19]; [@bib20]). In wild-type cells, Whi5 nuclear localization is transient and released by Cdc28-Cln3 activity, which enables progression to early G1 phase.

Further evidence that this is a *bona fide* G1 arrest, came from the finding that the *vac17Δ pep12-60*^*tsf*^ mutant with 1N DNA content, arrests as unbudded cells. We collected 1N DNA cells by flow cytometry, and determined their morphology by microscopy. After incubation at 37°C for 24 hr, 99% of the G1 cells were unbudded, in both the wild-type and *vac17Δ pep12-60*^*tsf*^ mutant ([Figure 3D](#fig3){ref-type="fig"}). Together these results indicate that the vacuole is required for early G1 progression.

TORC1-*SCH9* signaling from the new vacuole is required for cell-cycle progression {#s2-4}
----------------------------------------------------------------------------------

The above findings predict that regulation of the cell-cycle requires signaling from the vacuole. Evidence for a candidate signaling pathway came from studies which showed that deletion of *[T]{.ul}*arget *[O]{.ul}*f *[R]{.ul}*apamycin 1 (*TOR1*) showed synthetic growth defects with *vac17Δ* and *vac8Δ* ([@bib69]; [@bib18]) ([Figure 4---fiugre supplements 1A,B](#fig4s1){ref-type="fig"}). Similarly, another vacuole inheritance mutant, *myo2-N1304D*, was synthetic lethal with *tor1Δ* ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}). Notably, the *vac17Δ tor1Δ* double mutant showed an increase in cells arrested at G1 phase ([Figure 4A,B](#fig4){ref-type="fig"}). This arrest in G1 phase was similar to that observed for the *vac17Δ pep12-60*^*tsf*^ and *vac17Δ pep12Δ* mutants ([Figure 3---figure supplements 1A--C](#fig3s1){ref-type="fig"}). This suggests that TORC1 signaling from the vacuole may account at least in part for the G1 arrest observed in the *vac17Δ pep12-60*^*tsf*^ and *vac17Δ pep12Δ* mutants. Interestingly, the *vac17Δ tor1Δ* mutants generated a new vacuole in the daughter cells ([Figure 4C](#fig4){ref-type="fig"}). This suggests that *TOR1* functions after the synthesis of the new vacuole.10.7554/eLife.08160.009Figure 4.TORC1-*SCH9* signaling from the new vacuole is required for cell-cycle progression.(**A**) The *vac17Δ tor1Δ* double mutant exhibits an accumulation of G1 phase cells. Flow cytometry analysis with PI staining of yeast strains; wild-type, *vac17Δ*, *tor1Δ*, and *vac17Δ tor1Δ*. (**B**) Quantification of percent cells in G1 and G2 phase. Error bars; SD calculated from four independent experiments. (**C**) A new vacuole is synthesized in the new daughter cells of the *vac17Δ tor1Δ* double mutant. Wild-type, *vac17Δ, tor1Δ*, and *vac17Δ tor1Δ* cells which express Vph1-GFP from its endogenous locus, were pulse labeled with FM4-64. Arrowheads; new vacuole in daughter cells. (**D**) The kinase activity of target of rapamycin 1 (Tor1) is required for growth of the vacuole inheritance mutant, *vac17Δ*. Plasmids were transformed into a *vac17Δ tor1Δ* mutant containing pRS416 \[*URA3*\] *TOR1*. Plasmids tested were pRS315 \[*LEU2*\] (mock), pRS315 *HA*-*TOR1*, pRS315 *HA-tor1-D2275A*, or pRS315 *HA-tor1-D2294E*. Transformed colonies were cultured in liquid media and serial dilutions spotted onto SC+5-FOA or SC-Leu-Ura plates. Plates were incubated at 24°C for 4 days. (**E**) TORC1 signals from the new vacuole via Sch9. The phospho-mimetic *sch9-2D3E* mutant partially rescues the growth defect of the *vac17Δ tor1Δ* mutant. pRS413 (mock), pRS413 *VAC17*, pRS413 *TOR1*, pVT102-H (mock), pVT102-H *SCH9*, pVT102-H *sch9-2D3E*, or pVT102-H *sch9-5A* expressed in *vac17Δ tor1Δ* with pRS416 *TOR1*. Transformed colonies were cultured in liquid media and serial dilutions were spotted onto SC-His+5-FOA or SC-His-Ura plates, and incubated at 24°C for 4 days. (**F**) Sch9 signaling requires a functional vacuole. The phospho-mimetic *sch9-2D3E* mutant does not rescue the growth defect of the *vac17Δ pep12Δ* mutant. pRS413 (mock), pRS413 *VAC17*, pRS413 *TOR1*, pVT102-H (mock), pVT102-H *SCH9*, pVT102-H *sch9-2D3E*, or pVT102-H *sch9-5A* plasmids were expressed in a *vac17Δ pep12Δ* strain. Transformed colonies were cultured in liquid media and serial dilutions spotted onto an SC-His plate, and incubated at 24°C for 3 to 4 days.**DOI:** [http://dx.doi.org/10.7554/eLife.08160.009](10.7554/eLife.08160.009)10.7554/eLife.08160.010Figure 4---figure supplement 1.TORC1-*SCH9* is required for the viability of vacuole inheritance mutants.(**A**) The *tor1Δ* mutant exhibits a synthetic growth defect with *vac17Δ* and *vac8Δ*. Results of tetrad dissection of heterozygous diploids, *VAC17*/*vac17Δ TOR1*/*tor1Δ* and *VAC8*/*vac8Δ TOR1*/*tor1Δ*. *vac17Δ* = *17Δ*; *vac8Δ* = *8Δ*; *tor1Δ* = *1Δ*; *vac17Δ tor1Δ* or *vac8Δ tor1Δ* double mutants = *ΔΔ* are indicated. (**B**) Quantification of colony size, relative to average of wild-type colonies. A total of 34 tetrads and 39 tetrads were analyzed for *vac17Δ tor1Δ* and *vac8Δ tor1Δ*, respectively. (**C**) The *tor1Δ* mutant exhibits a synthetic growth defect with the *myo2-N1304D* mutant. Plasmids were transformed into a *myo2Δ* and *myo2Δ tor1Δ* strain containing YCp50 *MYO2.* Plasmids tested were pRS413 (mock), pRS413 *MYO2*, or pRS413 *myo2-N1304D*. Transformed colonies were cultured in liquid media and serial dilutions were spotted onto SC+5-FOA or SC-His-Ura plate, and incubated at 24°C for 4 days. (**D**) The *vac17Δ kog1-105* mutant showed synthetic growth defects. pRS313 (mock) and pRS415 (mock), pRS313 (mock) and pRS415 *VAC17*, pRS313 *KOG1* and pRS415 (mock), pRS313 *KOG1* and pRS415 *VAC17*, pRS313 *kog1-105* and pRS415 *VAC17*, or pRS313 *kog1-105* and pRS415 (mock) expressed in *vac17Δ kog1Δ* with pRS316 *KOG1*. Transformed colonies were cultured in liquid media and serial dilutions were spotted on SC-His-Leu+5-FOA or SC-His-Leu-Ura plates, and incubated at 24°C for 5 days.**DOI:** [http://dx.doi.org/10.7554/eLife.08160.010](10.7554/eLife.08160.010)

*TOR1* encodes a PIK-related protein kinase ([@bib1]). In yeast, Tor1 functions in the TORC1 complex, which is composed of Tor1/2, Kog1, Lst8, and Tco89 ([@bib41]). In yeast, TORC1 localizes on the vacuole membrane ([@bib51]; [@bib4]; [@bib59]; [@bib57]; [@bib8]; [@bib35]), and is a key determinant of nutrient status ([@bib21]). We found that the kinase activity of Tor1 was required for growth of *vac17Δ* ([Figure 4D](#fig4){ref-type="fig"}), and that the TORC1 specific subunit *KOG1* was also required for growth of *vac17Δ* ([Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}). In addition, the *lst8-15* temperature sensitive mutant is also synthetically lethal with *vac17Δ* ([@bib18]). These results suggest that the kinase activity of the TORC1 complex is required for normal growth of vacuole inheritance mutants.

One critical target of TORC1 is the Sch9 kinase, which shares overlapping functions with metazoan S6 kinase ([@bib5]; [@bib47]; [@bib17]). TORC1 directly phosphorylates Sch9 on several serines and threonines, and the phospho-mimetic *sch9-2D3E*, but not wild-type *SCH9* or the Ala-substituted *sch9-5A* mutant bypasses the TORC1 inhibitor, rapamycin ([@bib41]; [@bib59]). Notably, the phospho-mimetic *sch9-2D3E* mutant partially suppressed the growth defect of the *vac17Δ tor1Δ* mutant ([Figure 4E](#fig4){ref-type="fig"}), suggesting that the arrest of this mutant is due in part to defects in TORC1 mediated signaling via *SCH9*.

It was previously shown that Sch9-2D3E localizes on the vacuole membrane ([@bib59]). To test whether bypass of Tor1 by *sch9-2D3E* requires a functional vacuole, we tested whether *sch9-2D3E* can suppress the *vac17Δ pep12Δ* double mutant. Notably *sch9-2D3E* did not suppress the *vac17Δ pep12Δ* double mutant ([Figure 4F](#fig4){ref-type="fig"}). This suggests that a functional vacuole is required for the roles of the TORC1-*SCH9* pathway in cell-cycle progression from G1 phase.

While previous studies showed that TORC1 signals from the vacuole/lysosome ([@bib52]), and that Sch9 is activated in that location ([@bib59]), it was assumed that once Sch9 is activated, it no longer requires the vacuole for its further downstream functions. However our findings strongly suggest that the vacuole is required for Sch9 function(s) after Sch9 is phosphorylated by TORC1. One possible role of the vacuole in Sch9 function, is that target protein(s) of the Sch9 kinase must be present on the vacuole membrane. Alternatively or in addition, the full kinase activity of Sch9 may require other proteins that are on the vacuole membrane.

The newly synthesized vacuoles initially lack Sch9 and Fab1 {#s2-5}
-----------------------------------------------------------

If a cell does not receive a vacuole from the mother cell, the daughter cell generates a new vacuole. The observation that these new vacuoles grow to a specific size prior to generation of a bud, and that TORC1 signaling is also required, raised the possibility that that there are functional differences between newly synthesized vacuoles and inherited vacuoles. As a first approach, we tested the localization of several proteins that are involved in the TORC1 pathway, Tor1, Kog1 and Sch9. New vacuoles were defined as Vph1-CFP positive structures that failed to inherit FM4-64. Notably, in *vac17Δ* cells, GFP-Sch9 was defective in its localization to the new vacuoles, while the localization of Tor1 and Kog1 were unaffected ([Figure 5A,B](#fig5){ref-type="fig"}). To directly address whether Sch9 is eventually recruited to the newly formed vacuole and when this occurs, we correlated the presence of fluorescent signals for Vph1-CFP, Tor1-3xGFP and GFP-Sch9 ([Figure 5C,D](#fig5){ref-type="fig"}). These analyses show that Sch9 recruitment to the newly formed vacuole is slower than the recruitment of Vph1 and Tor1. Specifically, small budded cells did not have fluorescent signals for any of the proteins, which indicates that these small buds do not have a vacuole ([Figure 5C--F](#fig5){ref-type="fig"}). As the bud increases in size, in most cases, Vph1-CFP and Tor1-3xGFP appeared simultaneously ([Figure 5C](#fig5){ref-type="fig"}). This indicates that Tor1-3xGFP is immediately recruited to the newly formed vacuoles. Moreover in some small budded cells, Tor1-3xGFP was present without Vph1-CFP, which suggests that Tor1 may be present at endosomes in these small budded cells.10.7554/eLife.08160.011Figure 5.The newly synthesized vacuoles initially lack Sch9 and Fab1.(**A**) Sch9 does not localize to the newly formed vacuole. Indicated plasmids were transformed into wild-type and *vac17Δ* strains, which express Vph1-CFP from its endogenous locus: pRS416 *GFP-SCH9*, pRS416 *TOR1-3xGFP*^*(D330)*^, or pRS416 *KOG1-3xGFP*. Transformed cells were pulse labeled with FM4-64. Open arrowheads indicate a newly formed vacuole (Vph1-CFP) that was not inherited (lack of FM4-64), and is lacking GFP-Sch9. Closed arrowheads indicate a newly formed vacuole (Vph1-CFP) that was not inherited (lack of FM4-64), and with the GFP fusion protein, either Tor1-3xGFP^(D330)^ or Kog1-3xGFP. (**B**) Quantification of cells with fluorescence (Vph1-CFP and/or GFP) in daughter cells, where the mother has both GFP and FM4-64 signals. Averages from two independent experiments, with n = 69 and n = 104 for GFP-Sch9, n = 166 and n = 110 for Tor1-3xGFP^(D330)^, and n = 106 and n = 126 cells for Kog1-3xGFP, respectively. Open circles and squares indicate results of each experiment. (**C**) Tor1 is immediately recruited to the newly formed vacuoles. FM4-64 labeled *vac17Δ* cells that express Vph1-CFP from its endogenous locus, and Tor1-3xGFP expressed from a CEN plasmid with its endogenous promoter were used. Most small budded cells do not have fluorescent signals for any of the proteins, indicating that these small buds do not have a vacuole. In most cases, as the bud increases in size, Vph1-CFP and Tor1-3xGFP appear simultaneously. The middle line in the box plot indicates the median of the data set. The upper edge of the box indicates the 75th percentile of the data set, and the lower edge indicates the 25th percentile. ns; not a significant difference (p-value \> 0.10); \*\*\* (p-value \< 1 × 10^−6^). (**D**) Sch9 recruitment is delayed compared to Tor1, but eventually occurs. FM4-64 labeled *vac17Δ* cells expresses Vph1-CFP from its endogenous locus, and GFP-Sch9 expressed from a CEN plasmid with its endogenous promoter were used. In medium sized buds (0.62(±0.14) daughter size/mother size) only Vph1-CFP is present. The average bud size where both Vph1 and Sch9 are present is 0.79(±0.11). (**E**) Recruitment of Sch9-2D3E to the new vacuole is similar to the recruitment of wild-type Sch9. FM4-64 labeled *vac17Δ* cells which express Vph1-CFP from its endogenous locus, and GFP-Sch9-2D3E expressed from a CEN plasmid with its endogenous promoter were used. (**F**) The timing of the recruitment of Fab1 was similar to that observed for Sch9. FM4-64 labeled *vac17Δ* cells which express Vph1-CFP from its endogenous locus, and Fab1-3xGFP expressed from a CEN plasmid with its endogenous promoter were used. In medium sized buds (0.57(±0.13) daughter size/mother size) only Vph1-CFP is present. The average bud size where both Vph1 and Fab1 are present is 0.76(±0.10). (**G**) Model: The vacuole is essential for cell-cycle progression and functions in part through the TORC1 pathway. When the daughter cell receives vacuoles from the mother cell^(1)^, the daughter can progress from G1. If the cell fails to inherit a vacuole^(2)^, the cell generates a new vacuole^(3)^, which is followed by maturation of the new vacuole prior to G1 progression^(4)^. Without a functional vacuole, the daughter cell arrests at G1 phase^(5)^.**DOI:** [http://dx.doi.org/10.7554/eLife.08160.011](10.7554/eLife.08160.011)

In the *vac17Δ* mutant, although Tor1-3xGFP and Vph1-CFP are both present on the new vacuoles in medium buds (approximately 0.6 daughter size/mother size) ([Figure 5C](#fig5){ref-type="fig"}), GFP-Sch9 was generally not present until the bud size was larger (approximately 0.8) ([Figure 5D](#fig5){ref-type="fig"}). Thus Sch9 recruitment is delayed compared to Vph1 and Tor1, but eventually occurs. Notably the recruitment of the Sch9-2D3E mutant was similar to the recruitment of wild-type Sch9 ([Figure 5E](#fig5){ref-type="fig"}), indicating that the growth suppression of the *vac17Δ tor1Δ* mutant by *sch9-2D3E* is not due to a faster recruitment to the vacuole.

PI(3,5)P~2~, an inositol lipid which is present at the vacuole membrane, is required for vacuole membrane targeting of Sch9 ([@bib35]). To test whether the delay in Sch9 recruitment might be due to a delay in the generation of PI(3,5)P~2~ on newly formed vacuoles, we tested the timing of the recruitment of Fab1, the sole lipid kinase that generates PI(3,5)P~2~ ([@bib26]). Notably the timing of the recruitment of Fab1 was similar to that observed for Sch9. In a *vac17Δ* mutant which co-expressed Vph1-CFP and Fab1-3xGFP, only Vph1-CFP is present in medium buds (approximately 0.6 daughter size/mother size) ([Figure 5F](#fig5){ref-type="fig"}). The average bud size where both Vph1 and Fab1 are present was 0.76(±0.10). Thus Fab1 recruitment is delayed compared to Tor1, but is similar to that observed for Sch9. These observations suggest that there are differences between new vacuoles and inherited vacuoles, and that the newly synthesized vacuoles are missing specific components of mature vacuoles that are essential for cell-cycle progression.

Together, these observations demonstrate that a functional vacuole is crucial for cell-cycle progression at G1 phase, and that the TORC1-*SCH9* pathway is part of this critical function ([Figure 4G](#fig4){ref-type="fig"}). TORC1-*SCH9* signaling from the vacuole may be involved in G1 progression through its known functions in a ribosome biogenesis and translation ([@bib6]; [@bib38]; [@bib59]). Alternatively, the TORC1-*SCH9* pathway may signal the cell-cycle machinery that a functional vacuole is present and hence the cell is ready to progress from G1. Previous studies showed that Sch9 activity is critical for cell size ([@bib38]; [@bib59]), and that cell size correlates with vacuole size ([@bib15]). These observations together with the current study suggest that TORC1-*SCH9* localization and signaling from the vacuole is critical for the regulation of cell size. It is tempting to speculate that an analogous regulation of the cell-cycle occurs from endo-lysosomal membranes in other organisms. In addition, these findings lead to the hypothesis that cells possess novel checkpoint mechanisms that prevent cell-cycle progression at G1 phase in the absence of essential organelles.

Materials and methods {#s3}
=====================

Yeast strain and media {#s3-1}
----------------------

Yeast strains used are in [Table 1](#tbl1){ref-type="table"}. Deletion and fusion strains were constructed as described ([@bib42]). A *vac17Δ pep12-60*^*tsf*^ double mutant strain was made through mating *pep12-60*^*tsf*^ (CBY9) ([@bib12]) with *vac17Δ* (LWY5798) ([@bib30]). To generate a *GFP-PEP12*::*natNT2* strain, a *Cla*I-*Apa*I fragment from pBlueScript SK+ (pBS) *GFP-PEP12*::*natNT2* vector was integrated into the *PEP12* locus. Yeast cultures were grown at 24°C unless stated otherwise. Yeast extract-peptone-dextrose (1% yeast extract, 2% peptone, 2% dextrose; YEPD), synthetic complete (SC) lacking the appropriate supplement(s), and 5-FOA media were made as described ([@bib39]). Unless stated otherwise, SC medium contained 2% dextrose.10.7554/eLife.08160.012Table 1.Yeast strains used in this study**DOI:** [http://dx.doi.org/10.7554/eLife.08160.012](10.7554/eLife.08160.012)StrainGenotypeSourceFigureLWY7235*MATa, ura3-52, leu2-3,-112, his3-Δ200, trp1-Δ901, lys2-801, suc2-Δ9*([@bib10])--LWY11678*MATa, VPH1-GFP::KanMX*This study[Figures 1, 2, 4](#fig1 fig2 fig4){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}LWY12144*MATa, VPH1-GFP::KanMX*, *vac17Δ::TRP1*This study[Figures 1, 2, 4](#fig1 fig2 fig4){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}LWY15258*MATa/α, VAC17*/*vac17Δ::TRP1*, *PEP12*/*pep12Δ::KanMX*This study[Figure 2](#fig2){ref-type="fig"}LWY15612*MATa/α, VAC17*/*vac17Δ::TRP1*, *VPS45*/*vps45Δ::KanMX*This study[Figure 2](#fig2){ref-type="fig"}LWY14490*MATa, VPH1-GFP::KanMX, pep12Δ::KanMX*This study[Figure 2](#fig2){ref-type="fig"}LWY14493*MATa, VPH1-GFP::KanMX, vac17Δ::TRP1, pep12Δ::KanMX*This study[Figure 2](#fig2){ref-type="fig"}LWY15515*MATa, GFP-PEP12::natNT2*, *VPH1-CFP::KanMX*This study[Figure 2](#fig2){ref-type="fig"}LWY15506*MATa, GFP-PEP12::natNT2*, *VPH1-CFP::KanMX, vac17Δ::TRP1*This study[Figure 2](#fig2){ref-type="fig"}LWY15263, LWY14462, LWY12369*MATa*This study[Figures 3, 4](#fig3 fig4){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}LWY5798*MATa, vac17Δ::TRP1*([@bib58])--LWY15244, LWY14468, LWY12366*MATa, vac17Δ::TRP1*This study[Figures 3, 4](#fig3 fig4){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}CBY9*MATα, pep12-60*^*tsf*^*, leu2-3,112*::*pBHY11 CPY-Inv LEU2*([@bib12])--LWY15250*MATa, pep12-60*^*tsf*^This study[Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}LWY15249*MATa, vac17Δ::TRP1, pep12-60*^*tsf*^This study[Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}LWY15799*MATa, WHI5-3xGFP::His3MX*This study[Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}LWY15791*MATa, WHI5-3xGFP::His3MX, vac17Δ::TRP1*This study[Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}LWY15789*MATa, WHI5-3xGFP::His3MX, pep12-60*^*tsf*^This study[Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}LWY15814*MATα, WHI5-3xGFP::His3MX, vac17Δ::TRP1, pep12-60*^*tsf*^This study[Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}LWY12364*MATa, tor1Δ::KanMX*This study[Figure 4](#fig4){ref-type="fig"}LWY12367*MATα, vac17Δ::TRP1*, *tor1Δ::KanMX*This study[Figure 4](#fig4){ref-type="fig"}LWY12168*MATa, VPH1-GFP::KanMX, tor1Δ::KanMX*This study[Figure 4](#fig4){ref-type="fig"}LWY12193*MATa, VPH1-GFP::KanMX, vac17Δ::TRP1*, *tor1Δ::KanMX*This study[Figure 4](#fig4){ref-type="fig"}LWY14142*MATa, vac17Δ::TRP1*, *tor1Δ::KanMX,* pRS416 *TOR1*This study[Figure 4](#fig4){ref-type="fig"}LWY12358, LWY14487*MATa, vac17Δ::TRP1*, *pep12Δ::KanMX*This study[Figure 4](#fig4){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}LWY11657*MATa, VPH1-CFP::KanMX*This study[Figure 5](#fig5){ref-type="fig"}LWY13781*MATa, VPH1-CFP::KanMX, vac17Δ::TRP1*This study[Figure 5](#fig5){ref-type="fig"}LWY15610*MATa/α, VAC8*/*vac8Δ::HIS3*, *PEP12*/*pep12Δ::KanMX*This study[Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}LWY15614*MATa/α, VAC8*/*vac8Δ::HIS3*, *VPS45*/*vps45Δ::KanMX*This study[Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}LWY2947*MATα, myo2Δ::TRP1,* YCp50*-MYO2*([@bib14])[Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}LWY12443*MATα, pep12Δ::KanMX, myo2Δ::TRP1,* YCp50*-MYO2*This study[Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}LWY15581*MATα, vps45Δ::KanMX, myo2Δ::TRP1,* YCp50*-MYO2*This study[Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}LWY14497*MATa, pep12Δ::KanMX*This study[Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}LWY14475*MATa, vps45Δ::KanMX*This study[Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}LWY14463*MATa, vac17Δ::TRP1, vps45Δ::KanMX*This study[Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}LWY1*MATa/α, TOR1/tor1Δ::KanMX*This study[Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}LWY15616*MATa/α, VAC8*/*vac8Δ::HIS3*, *TOR1*/*tor1Δ::KanMX*This study[Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}LWY12001*MATa, tor1Δ::KanMX, myo2Δ::TRP1,* YCp50*-MYO2*This study[Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}LWY13595*MATa, vac17Δ::TRP1, kog1Δ::KanMX,* pRS316 *KOG1*This study[Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}[^1]

In vivo labeling of vacuoles {#s3-2}
----------------------------

Vacuoles were labeled in vivo with N-(3-triethelammoniumpropyl)-4-(6 (4-(diethylamino) phenyl) hexatrienyl) pyridinium dibromide (FM4-64 \[SynaptoRed C2\]; Biotium, Hayward, CA, United States) essentially as described ([@bib30]). In brief, a 2 mg/ml stock solution of FM4-64 in dimethyl sulfoxide was added to early log phase cultures for a final concentration of 80 μM. After 1 hr of labeling, cells were washed and then chased in fresh liquid medium for 3--4 hr.

Plasmids {#s3-3}
--------

Plasmids used are in [Table 2](#tbl2){ref-type="table"}. To generate an integration vector to express GFP fused to Pep12 from the *PEP12* gene locus, pBS *GFP-PEP12*::*natNT2* was made. A 1.4 kb *Cla*I-*BstB*I fragment of *PEP12* was inserted at the *Cla*I site of pBS. To insert GFP at the N-terminus of Pep12, an *Avr*II site was generated at the N-terminus of *PEP12* by PCR using primers (5′-CAA TAA TTG TGT TGA GAT Gcc tag gTC GGA AGA CGA ATT TTT TGG-3′) and (5′-CCA AAA AAT TCG TCT TCC GAc cta ggC ATC TCA ACA CAA TTA TTG-3′). The GFP fragment was amplified from pFA6a GFP(S65T)-KanMX ([@bib42]) by PCR using primers (5′-TGA gct agc AGT AAA GGA GAA GAA CTT TTC ACT GG-3′) and (5′-TGA act agt gtt aat taa ccc ggg gat ccg tcg acc TTT GTA TAG TTC ATC CAT GCC-3′). The *Nhe*I-*Spe*I fragment of GFP was inserted at the *Avr*II site. The *natNT2* maker was amplified from pFA6a *natNT2* ([@bib33]) by PCR using primers (5′-CTG tgt aca CAG CGA CAT GGA GGC-3′) and (5′-TCA tgt aca ACA GGT GTT GTC CTC TGA G-3′). A *BsrG*I fragment of *natNT2* was inserted into the *BsrG*I site at 3′ UTR of the *PEP12*.10.7554/eLife.08160.013Table 2.Plasmids used in this study**DOI:** [http://dx.doi.org/10.7554/eLife.08160.013](10.7554/eLife.08160.013)Plasmid nameDescriptionSourceFigurepBlueScript SK+*GFP-PEP12*::*natNT2*AmpThis study[Figure 2](#fig2){ref-type="fig"}pRS416 *TOR1*CEN, *URA3*This study[Figure 4](#fig4){ref-type="fig"}pRS413CEN, *HIS3*([@bib55])[Figure 4](#fig4){ref-type="fig"}pRS315 *HA*-*TOR1*CEN, *HIS3*Gift from Dr Robbie Loewith[Figure 4](#fig4){ref-type="fig"}pRS315 *HA-tor1-D2275A*CEN, *HIS3*This study[Figure 4](#fig4){ref-type="fig"}pRS315 *HA-tor1-D2294E*CEN, *HIS3*This study[Figure 4](#fig4){ref-type="fig"}pRS413 *VAC17*CEN, *HIS3*This study[Figure 4](#fig4){ref-type="fig"}pRS413 *TOR1*CEN, *HIS3*This study[Figure 4](#fig4){ref-type="fig"}pVT102-H2μ, *HIS3*([@bib60])[Figure 4](#fig4){ref-type="fig"}pVT102-H *SCH9*2μ, *HIS3*This study[Figure 4](#fig4){ref-type="fig"}pVT102-H *sch9-2D3E*2μ, *HIS3*This study[Figure 4](#fig4){ref-type="fig"}pVT102-H *sch9-5A*2μ, *HIS3*This study[Figure 4](#fig4){ref-type="fig"}pRS416 *GFP-SCH9*CEN, *URA3*([@bib59])[Figure 5](#fig5){ref-type="fig"}pRS416 *GFP-sch9-2D3E*CEN, *URA3*This study[Figure 5](#fig5){ref-type="fig"}pRS416 *TOR1-3xGFP*^*(D330)*^CEN, *URA3*This study[Figure 5](#fig5){ref-type="fig"}pRS416 *KOG1-3xGFP*CEN, *URA3*This study[Figure 5](#fig5){ref-type="fig"}pRS416 *FAB1-3xGFP*CEN, *URA3*([@bib34])[Figure 5](#fig5){ref-type="fig"}pRS413CEN, *HIS3*([@bib55])[Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}pRS413 *MYO2*CEN, *HIS3*([@bib14])[Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}pRS413 *myo2-N1304D*CEN, *HIS3*([@bib13])[Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}pRS416 *KOG1*CEN, *URA3*([@bib35])[Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}pRS313CEN, *HIS3*([@bib55])[Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}pRS415CEN, *LEU2*([@bib55])[Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}pRS415 *VAC17*CEN, *LEU2*([@bib37])[Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}pRS313 *KOG1*CEN, *HIS3*([@bib46])[Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}pRS313 *kog1-105*CEN, *HIS3*([@bib46])[Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}

pRS416 *TOR1* includes 227 bp upstream and 944 bp downstream of the *TOR1* gene, the same region as pRS315 *HA-TOR1* (gift from Dr Robbie Loewith).

For generation of *tor1*-*D2275A*, and *-D2294E* kinase dead mutants ([@bib68]; [@bib1]), the *TOR1* gene was mutagenized by site-directed mutagenesis using the following primers: (D2275A-S) 5′-GTT ATA TTC TGG GAC TAG GTG cTC GCC ATC CAA GCA ACC TG-3′, (D2275A-AS) 5′-CAG GTT GCT TGG ATG GCG AgC ACC TAG TCC CAG AAT ATA AC-3′, (D2294E-S) 5′-CAC CGG TAA AGT TAT CCA CAT TGA aTT CGG CGA TTG TTT TGA AGC-3′, (D2294E-AS) 5′-GCT TCA AAA CAA TCG CCG AAt TCA ATG TGG ATA ACT TTA CCG GTG-3′.

For generation of pVT102-H *SCH9*, *SCH9* was amplified by PCR using primers (5′-ATA gga tcc ATG ATG AAT TTT TTT ACA TCA AAA TCG-3′) and (5′-GAG tct aga TAT TTC GAA TCT TCC ACT GAC AAA TTC-3′). A *BamH*I-*Xba*I fragment of *SCH9* was inserted into the *BamH*I, *Xba*I sites of pVT102-H ([@bib60]).

For generation of phospho-mimetic *sch9-2D3E* and non-phospho *sch9-5A* mutant ([@bib59]), the *SCH9* gene was mutagenized by site-directed mutagenesis using the following primers: (T723D/S726D-S) 5′-CC GAT GAT GAC TGC Tga CCC GCT Aga TCC AGC CAT GCA AGC AAA G-3′, (T723D/S726D-AS) 5′-CTT TGC TTG CAT GGC TGG Atc TAG CGG Gtc AGC AGT CAT CAT CGG-3′, (T737E--S) 5′-CAA GCA AAG TTT GCT GGT TTC gaa TTT GTT GAT GAG TCC GCC ATC-3′, (T737E-AS) 5′-GAT GGC GGA CTC ATC AAC AAA ttc GAA ACC AGC AAA CTT TGC TTG-3′, (S758E/S765E--S) 5′-CCT ACA AAA Cga GTA CTT TAT GGA ACC TGG Tga aTT TAT CCC GGG-3′, (S758E/S765E-AS) 5′-CCC GGG ATA AAt tcA CCA GGT TCC ATA AAG TAC tcG TTT TGT AGG-3′, (T723A/S726A-S) 5′-CCG ATG ATG ACT GCT gCC CCG CTA gCT CCA GCC ATG CAA GCA AAG-3′, (T723A/S726A-AS) 5′-CTT TGC TTG CAT GGC TGG AGc TAG CGG GGc AGC AGT CAT CAT CGG-3′, (T737A-S) 5′-CAA GCA AAG TTT GCT GGT TTC gCC TTT GTT GAT GAG TCC GCC ATC-3′, (T737A-AS) 5′-GAT GGC GGA CTC ATC AAC AAA GGc GAA ACC AGC AAA CTT TGC TTG-3′, (S758A/S765A-S) 5′-CCT ACA AAA CgC GTA CTT TAT GGA ACC TGG TgC CTT TAT CCC GGG-3′, (S758A/S765A-AS) 5′-CCC GGG ATA AAG GcA CCA GGT TCC ATA AAG TAC GcG TTT TGT AGG-3′.

For generation of pRS416 *TOR1-3xGFP*^*(D330)*^, an *Xba*I site was generated at the D330 position of *TOR1* with PCR using primers (5′-GTT TAT AAG GAA ATC TTG TTT TTG AAG tct Aga CCC TTT TTG AAT CAA GTG TTC-3′) and (5′-GAA CAC TTG ATT CAA AAA GGG tcT aga CTT CAA AAA CAA GAT TTC CTT ATA AAC-3′). A 3xGFP fragment was amplified from pFA6a 3xGFP-TRP1 by PCR using primers (5′-CGG tct aga GGG TTA ATT AAC GTG AGC AAG GG-3′) and (5′-AAT CTC GAG gct agc GGG GAT CCG TCG ACC CTT GTA CAG CTC GTC CAT GC-3′). An *Xba*I-*Nhe*I fragment of 3xGFP was inserted at the *Xba*I site ([@bib35]).

For generation of pRS416 *KOG1-3xGFP*, an *Xba*I site was generated at the C-terminal end of *KOG1* by PCR using primers (5′-GAG AAT TGA TTA TTT Ttc tag aTA TGT GCC ATT TCT TTT TTT TTC-3′) and (5′-GAA AAA AAA AGA AAT GGC ACA TAt cta gaA AAA TAA TCA ATT CTC-3′). The 3xGFP fragment was amplified by PCR using primers (5′-TCT AGA GGG TTA ATT tct aga AGC AAG GGC GAG GAG C-3′) and (5′-AAT CTC GAG gct agc GTT AAT TAA CCC GGG GAT CCG TCG ACC-3′). The *Xba*I-*Nhe*I fragment of 3xGFP was inserted at the *Xba*I site ([@bib35]).

Flow cytometry analysis {#s3-4}
-----------------------

Quantitation of nuclear DNA was determined as follows: Cells were stained with PI and analyzed by FACS analysis (MACSQuant 1; Miltenyi Biotec, Germany). In most experiments, 10,000 cells were examined. Yeast were incubated at 24°C overnight, and then sifted to 37°C for 0, 2, 4, 8, 12, or 24 hr. At the start of the experiment, yeast were in log phase growth. 1.0 OD~600~ yeast cultures were collected, washed with 50 mM of Tris-HCl \[pH7.5\], and fixed with 70% EtOH. Cells were then washed twice with 50 mM of Tris-HCl \[pH7.5\], followed by sonication. Cells were treated with RNaseA (Sigma--Aldrich R6513; final 2 mg/ml in 50 mM of Tris-HCl \[pH7.5\]) at 37°C overnight. Cells were then treated with Pepsin (Sigma--Aldrich 7000; final 5 mg/ml) at room temperature for 30 min, and stained with PI (Sigma--Aldrich 4170) 50 mg/ml in 180 mM Tris-HCl \[pH7.5\], 180 mM NaCl, 70 mM MgCl~2~ for 1 hr at room temperature. The PI stained cells were analyzed by FACS.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for submitting your work entitled "The vacuole/lysosome is required for cell-cycle progression" for peer review at *eLife*. Your submission has been favorably evaluated by Vivek Malhotra (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The reviewers found the idea of a checkpoint linking vacuole inheritance and/or biogenesis to the cell cycle potentially important. However, substantial discussion amongst the reviewers debated whether you have identified a bona fide cell growth checkpoint or simply confirmed that TORC1 signals from the vacuole membrane. It was appreciated that this may not be definitively distinguished at this stage and the reviewers have collectively offered a few experiments that they feel can raise the paper to the threshold of acceptance.

Essential revisions:

1\) It wasn\'t clear from the data presented for the double mutants whether "G1 arrest" only refers to the DNA content, and whether these are unbudded cells or budded cells with unduplicated nuclei. This is an important distinction that needs to be resolved as it helps to form whether the signal is controlling multiple aspects of cell cycle coordination, or just one (i.e. chromosome duplication and/or cell growth and cytokinesis).

Similarly, the authors state in the Results and Discussion section that: "These observations strongly suggest that cells without a functional vacuole first arrest at G1 phase, and then eventually die." This and the aforementioned issue could be addressed by making movies with the double mutant (rather than simply taking static pictures) with the Vph1-GFP and a second tagged marker (e.g. nuclear). From the data presented this should be easy for the authors to do.

2\) When is Sch9 recruited to a newly formed vacuole? [Figure 5](#fig5){ref-type="fig"} shows that there is a defect or delay in Sch9 recruitment to the vacuole of *vac17Δ* cells, but does not reveal when during the process of vacuole biogenesis this problem is resolved or how this relates to eventual bud growth. Does Sch9-2D3E localize to the vacuole, or does it bypass TORC1 signaling altogether?

Related, you may wish to address the following questions regarding TORC1 and Sch9 signaling that were raised during review:

The Weisman group has previously shown that PI(3,5)P~2~ on the vacuole membrane is required vacuole membrane targeting of Sch9 ([@bib35]). The difference between the 'new' and maternal vacuoles in sustaining TORC1 signaling (and, therefore, cell growth) may reflect the acquisition of PI(3,5)P~2~ on the new vacuole membrane. Does the 'new' vacuole in *vac17* cells ([Figure 4--figure supplement 1](#fig4s1){ref-type="fig"}) contain PI(3,5)P~2~? It might also be informative to determine if synthetic targeting of Sch3-2D3E to the 'old' vacuole (e.g., by fusion to Vph1) rescue the cell growth defect?

3\) The Barbet et al., MBoC, 1996 study (PMID: 8741837) on the role of Tor signaling in the regulation of cell cycle progression out of G1 should be cited and discussed.

10.7554/eLife.08160.015

Author response

*1) It wasn\'t clear from the data presented for the double mutants whether "G1 arrest" only refers to the DNA content, and whether these are unbudded cells or budded cells with unduplicated nuclei. This is an important distinction that needs to be resolved as it helps to form whether the signal is controlling multiple aspects of cell cycle coordination, or just one (i.e. chromosome duplication and/or cell growth and cytokinesis)*.

We tested and found that the *vac17∆ pep12-60*^*tsf*^ mutant arrests with 1N DNA content as unbudded cells. This data is now shown in new [Figure 3D](#fig3){ref-type="fig"} and presented in the text as follows: "Further evidence that this is a bona fide G1 arrest, came from the finding that the *vac17∆ pep12-60*^*tsf*^ mutant with 1N DNA content, arrests as unbudded cells. \[...\] Together these results indicate that the vacuole is required for early G1 progression." Note that at least 400 cells were counted for each experiment, and three independent experiments were performed (see [Figure 3D](#fig3){ref-type="fig"} legend).

*Similarly, the authors state: in the Results and Discussion section that: "These observations strongly suggest that cells without a functional vacuole first arrest at G1 phase, and then eventually die. This and the aforementioned issue could be addressed by making movies with the double mutant (rather than simply taking static pictures) with the Vph1-GFP and a second tagged marker (e.g. nuclear). From the data presented this should be easy for the authors to do*.

To gain additional insight into whether cells without a functional vacuole first arrest at G1 phase and then eventually die, we performed statistical analyses of the degree of G1 arrest compared with the degree of cell death. These new analyses are presented in the text as follows:

"Importantly, at 8, 12 and 24 hours after the shift to 37°C, the differences between the the *vac17∆ pep12-60*^*tsf*^ double mutant exhibited a statistically significant increase in G1 arrested cells (all p-values \< 1x10^-3^). \[...\] In wild-type cells, Whi5 nuclear localization is transient and released by Cdc28-Cln3 activity, which enables progression to early G1 phase."

Based on these new analyses it did not appear essential to the current study to further analyze the relative timing of G1 arrest and cell death by performing movies of individual cells. In addition because the increase in cell death does not occur until at least 24 hr at 37°C, it would be difficult if not impossible to generate time-lapse movies of this length of individual fluorescently labeled cells of the v*ac17∆ pep12-60*^*tsf*^ double mutant, to determine whether all cells eventually die and to determine a time-course of cell death.

*2) When is Sch9 recruited to a newly formed vacuole?* [*Figure 5*](#fig5){ref-type="fig"} *shows that there is a defect or delay in Sch9 recruitment to the vacuole of* vac17Δ *cells, but does not reveal when during the process of vacuole biogenesis this problem is resolved or how this relates to eventual bud growth*.

We agree that this is a critical question. We showed there is less Sch9 on the newly formed vacuole in [Figure 5](#fig5){ref-type="fig"}. To directly address whether Sch9 is eventually recruited to the newly formed vacuole and when this occurs, we correlated the presence of fluorescent signals, for Vph1-CFP, Tor1-3xGFP and GFP-Sch9 ([Figure 5C](#fig5){ref-type="fig"}). This new analysis shows that Sch9 recruitment to the newly formed vacuole is slower than the recruitment of Vph1 and Tor1. Specifically, small budded cells do not have fluorescent signals for any of the proteins indicating these small buds do not have a vacuole. In most cases, as the bud increases in a size, Vph1-CFP and Tor1-GFP appear simultaneously. This indicates that Tor1-GFP is immediately recruited to the newly formed vacuoles. In contrast, in the *vac17∆* mutant which co-expresses Vph1-CFP and GFP-Sch9, in medium sized buds (0.62(±0.14) daughter size/mother size) only Vph1-CFP is present. The average bud size where both Vph1 and Sch9 are present is 0.79(±0.11). Thus Sch9 recruitment is delayed compared to Tor1, but eventually occurs.

Does Sch9-2D3E localize to the vacuole, or does it bypass TORC1 signaling altogether?

The following text is now included in the manuscript: "It was previously shown that Sch9-2D3E localizes on the vacuole membrane ([@bib59] Mol. Cell). \[...\] This suggests that a functional vacuole is required for the roles of the TORC1-*SCH9* pathway in cell-cycle progression from G1 phase."

*Related, you may wish to address the following questions regarding TORC1 and Sch9 signaling that were raised during review*:

*The Weisman group has previously shown that PI(3,5)P*~*2*~ *on the vacuole membrane is required vacuole membrane targeting of Sch9 (*[@bib35]*). The difference between the 'new' and maternal vacuoles in sustaining TORC1 signaling (and, therefore, cell growth) may reflect the acquisition of PI(3,5)P*~*2*~ *on the new vacuole membrane. Does the 'new' vacuole in vac17 cells (*[*Figure 4--figure supplement 1*](#fig4s1){ref-type="fig"}*) contain PI(3,5)P*~*2*~*? It might also be informative to determine if synthetic targeting of Sch3-2D3E to the 'old' vacuole (e.g., by fusion to Vph1) rescue the cell growth defect?*

We thank the reviewers for this suggestion. To test whether the delay in Sch9 recruitment might be due to a delay in the generation of PI(3,5)P~2~ on the newly formed vacuoles, we tested the timing of the recruitment of Fab1, the sole lipid kinase for generation of PI(3,5)P~2~. Notably the timing of the recruitment of Fab1 was similar to that observed for Sch9. In a *vac17∆* mutant that co-expressed Vph1-CFP and Fab1-3xGFP, in medium sized buds (0.57(±0.13) daughter size/mother size) only Vph1-CFP is present. The average bud size where both Vph1 and Fab1 are present is 0.76(±0.10). Thus Fab1 recruitment is delayed compared to Tor1, and is similar to the recruitment of Sch9.

*3) The Barbet et al., MBoC, 1996 study (PMID: 8741837) on the role of Tor signaling in the regulation of cell cycle progression out of G1 should be cited and discussed*.

Thank you for this suggestion. We now cite and discuss [@bib6] and state as follows:

"Together, these observations demonstrate that a functional vacuole is crucial for cell-cycle progression at G1 phase, and that the TORC1-*SCH9* pathway is part of this critical function ([Figure 4G](#fig4){ref-type="fig"}). TORC1-*SCH9* signaling from the vacuole may be involved in G1 progression through its known functions in a ribosome biogenesis and translation ([@bib6]; [@bib38]; [@bib59])".

[^1]: Each above haploid strain is ura3-52, leu2-3,-112, his3-*Δ*200, trp1-*Δ*901, lys2-801, suc2-*Δ*9, and diploid strain is ura3-52/ura3-52, leu2-3,-112/leu2-3,-112, his3-*Δ*200/his3-*Δ*200, trp1-*Δ*901/trp1-*Δ*901, lys2-801/lys2-801, suc2-*Δ*9/suc2-*Δ*9.
